R&D Activities Sample Clauses

R&D Activities. R&D Activities refer to all activities dedicated to the research and development of products and any other supporting products, which are provided to the Company by the Developer in the form of services, and should be beneficial to the further technical improvement of products. See Appendix A for details.
Sample 1Sample 2
AutoNDA by SimpleDocs
R&D Activities and customized solution The ability to offer customized solutions is highly appreciated by top clients of automotive and fashion industry in Europe. 15 Relationship with design world Relationship with design world Since many years Xxxxxxxxx has developed an extremely rewarding relationship with the excellence of the design community, both top designers and emerging creative avant- gardes. It seems that this community fully understand the endless potential of the material and its ability to renew itself constantly. Relationship with design community UDK – Universität der Künste Can you Imagine? Project Xxxxxxxxx® - MAXXI XXXXXXXX XXXXXXXXX XXXXXX XXXXXXXXXX XXXXXXX XXXXXXX XXXXXX XXXXXXX XXXXXXXXXXXX XXXXX XXXX XXXXXX XXX XXXX XXXXX XXXXX XXXXXX XXXXXXX XXXXXXX RAW EDGE - XXXX XXX E XXXX XXXXXX XXXXXXXXX XXXXXXX 18 Relationship with Who is on Next? design community In collaboration with Vogue Italia and AltaRoma AltaModa British Fashion Council XXXXXXX XXXXXXXX XXXXXXX XXXXXX AU JOUR LE JOUR CO|TE XXXXXXXX XXXXXXX XXXXX XXXXX XXXXX XXXXXXXXXXX XXXXXXX XXXXXXXXXXX XXXXXX XXXX TO LONG-XXX XXXXXX XXXXX Interior Collection Xxxxxx - Xxxxxxxxxx Relationship with Japan A significant part of our raw materials is imported from Japan. In addition, there is a constant flow of products and samples in both directions between Japan and Europe. Relationship with Japan Xxxxxxxxx R&D Center Toray R&D Center A global brand A global brand Xxxxxxxxx® brand is under the process of globalization and its core values are getting recognized also outside Europe. In particular, Xxxxxxxxx has stimulated the Japanese market and is planning to approach it directly in the near future. Car Graphic: December 2010 Xxxxxx: December, 15th 2010 Car Graphic: January 2011 Japanese market is very sensitive to “Made in Italy” and European products, especially luxury brands. Most of our key European customers act on a global basis and have an important presence in Japan A global brand Free trade will create new value both for European and Japanese industry and will help Xxxxxxxxx and its customers to better operate in a global market Thank
Sample 1
R&D Activities. Cytonics shall keep CMH reasonably apprised of any and all existing autologous product development activities directly related to Human Applications.
Sample 1
R&D Activities. Cytonics shall keep A2Mcyte reasonably apprised of any and all existing autologous product development activities directly related to Orthopedic Applications.
Sample 1
R&D Activities. Cytonics shall keep Astaria reasonably apprised of any and all existing autologous product development activities directly related to Veterinary Applications.
Sample 1
R&D Activities. Notwithstanding anything to the contrary in the Agreement, with respect to calendar year 2010, the Parties have reallocated Research and Development activities, such that the Research Plan and Development Plan for calendar year 2010 are set forth in Exhibit A, Exhibit B and Exhibit C attached, and, with respect to Q42009, the Parties have reallocated Research and Development activities as set forth in Exhibit X. XXXXX shall fund the Research and Development activities for calendar year 2010 as set forth in Exhibit X. XXXXX shall fund all of ROCHE’s Research and Development activities for Q42009, and shall fund all of SYNTA’s Research and Development activities for Q42009 in accordance with the revised budget set forth on page 26 of the Powerpoint presentation dated August 31, 2009, titled “CRAC Channel Blocker Project, JRDC Report” (copy attached as Exhibit D) and presented to the JSC (the “Revised Q42009 Budget”), which the Parties hereby ratify as an amendment to the Research Plan and Development Plan for Q42009.
Sample 1
R&D Activities 
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs

Related to R&D Activities

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Permitted Activities The Executive shall devote his entire business time, attention and energies to the Business of the Employer and shall not during the Term be engaged (whether or not during normal business hours) in any other business or professional activity, whether or not such activity is pursued for gain, profit or other pecuniary advantage; but this shall not be construed as preventing the Executive from:

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

  • LIMITED ACTIVITIES Except for activities in connection with the Offering, the Formation Transactions or in the ordinary course of business, the Operating Partnership and the Operating Partnership Subsidiaries have not engaged in any material business or incurred any material obligations.

  • Market Activities The Company will not, directly or indirectly, (i) take any action designed to cause or result in, or that constitutes or might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Common Stock or (ii) sell, bid for or purchase the Common Stock, or pay anyone any compensation for soliciting purchases of the Common Stock.

  • Restricted Activities The Executive agrees that some restrictions on his activities during and after his employment are necessary to protect the goodwill, Confidential Information and other legitimate interests of the Company and its Affiliates:

  • Outside Activities Subject to the Articles of Incorporation and any agreements entered into by the General Partner or its Affiliates with the Partnership or a Subsidiary, any officer, director, employee, agent, trustee, Affiliate or stockholder of the General Partner shall be entitled to and may have business interests and engage in business activities in addition to those relating to the Partnership, including business interests and activities substantially similar or identical to those of the Partnership. Neither the Partnership nor any of the Limited Partners shall have any rights by virtue of this Agreement in any such business ventures, interest or activities. None of the Limited Partners nor any other Person shall have any rights by virtue of this Agreement or the partnership relationship established hereby in any such business ventures, interests or activities, and the General Partner shall have no obligation pursuant to this Agreement to offer any interest in any such business ventures, interests and activities to the Partnership or any Limited Partner, even if such opportunity is of a character which, if presented to the Partnership or any Limited Partner, could be taken by such Person.

  • Activities Except with the prior written consent of the Board, Executive will not during his employment with the Company undertake or engage in any other employment, occupation or business enterprise, other than ones in which Executive is a passive investor. Executive may engage in civic and not-for-profit activities so long as such activities do not materially interfere with the performance of his duties hereunder.

  • Research Program 2.1 University will use reasonable efforts to conduct the Research Program described in Attachment A which is hereby incorporated in full by reference (“Research Program”), and will furnish the facilities necessary to carry out said Research Program. The Research Program will be under the direction of _____________________ (“Principal Investigator”), or his or her successor as mutually agreed to by the Parties and will be con­ducted by the Principal Investigator at the University.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!